ClinVar Miner

Submissions for variant NM_000329.3(RPE65):c.131G>A (p.Arg44Gln) (rs61751282)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV000701390 SCV000830190 pathogenic Leber congenital amaurosis 2; Retinitis pigmentosa 20 2019-11-19 criteria provided, single submitter clinical testing This sequence change replaces arginine with glutamine at codon 44 of the RPE65 protein (p.Arg44Gln). The arginine residue is highly conserved and there is a small physicochemical difference between arginine and glutamine. This variant is present in population databases (rs61751282, ExAC 0.02%). This variant has been reported to be homozygous or compound heterozygous in several individuals affected with Leber's congenital amaurosis (PMID: 11462243, 19431183, 15024725, 20079931, 18539930). In at least one individual the data is consistent with the variant being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 98840). Experimental studies have shown that this missense results in a significant reduction in RPE65 enzymatic activity (PMID: 16150724). For these reasons, this variant has been classified as Pathogenic.
Retina International RCV000085166 SCV000117303 not provided not provided no assertion provided not provided
Laboratory of Genetics in Ophthalmology,Institut Imagine RCV001250676 SCV001425546 likely pathogenic Leber congenital amaurosis 2 no assertion criteria provided research

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.